Oxazoles for treating cytokine mediated diseases
    8.
    发明授权
    Oxazoles for treating cytokine mediated diseases 失效
    用于治疗细胞因子介导的疾病的恶唑

    公开(公告)号:US06288062B1

    公开(公告)日:2001-09-11

    申请号:US09467164

    申请日:1999-12-20

    IPC分类号: A61K3535

    CPC分类号: C07D413/04

    摘要: This invention relates to the novel oxazole compounds of Formula (I) and novel pharmaceutical compositions comprising a compound of Formula (I) and a pharmaceutically acceptable diluent or carrier. This invention also relates to a method of inhibiting cytokines and the treatment of cytokine mediated diseases, in mammals, thereby by administration of an effective amount of a compound according to Formula (I).

    摘要翻译: 本发明涉及式(I)的新型恶唑化合物和包含式(I)化合物和药学上可接受的稀释剂或载体的新型药物组合物。 本发明还涉及在哺乳动物中抑制细胞因子和细胞因子介导的疾病的治疗方法,从而通过施用有效量的根据式(I)的化合物。